An introduction to pancreatic adenocarcinoma genetics, pathology and therapy.

scientific article

An introduction to pancreatic adenocarcinoma genetics, pathology and therapy. is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.4161/CBT.307
P698PubMed publication ID12642681
P5875ResearchGate publication ID10850676

P50authorRalph H. HrubanQ21063634
Manuel HidalgoQ37392552
Charles J YeoQ96191880
P2093author name stringScott E Kern
P433issue6
P921main subjectpancreatic adenocarcinomaQ18556189
adenocarcinomaQ356033
P304page(s)607-613
P577publication date2002-11-01
P1433published inCancer Biology and TherapyQ2544651
P1476titleAn introduction to pancreatic adenocarcinoma genetics, pathology and therapy
P478volume1

Reverse relations

cites work (P2860)
Q52652984A new combined criterion to better predict malignant lesions in patients with pancreatic cystic neoplasms.
Q40172830Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion
Q36667498Adverse prognosis of epigenetic inactivation in RUNX3 gene at 1p36 in human pancreatic cancer
Q40414760Analysis of genomic DNA alterations and mRNA expression patterns in a panel of human pancreatic cancer cell lines
Q31121505Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays
Q24337345Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer
Q34101151Expression of oncogenic K-ras and loss of Smad4 cooperate to induce the expression of EGFR and to promote invasion of immortalized human pancreas ductal cells
Q35102998Functional defects in the fanconi anemia pathway in pancreatic cancer cells
Q37772497Gene-expression profiling in pancreatic cancer
Q37148201Genetic and epigenetic alterations of familial pancreatic cancers
Q38931858Human pancreatic cancer progression: an anarchy among CCN-siblings
Q43127970Imaging human pancreatic cancer xenografts by targeting mutant KRAS2 mRNA with [(111)In]DOTA(n)-poly(diamidopropanoyl)(m)-KRAS2 PNA-D(Cys-Ser-Lys-Cys) nanoparticles
Q37408967Immortalizing the complexity of cancer metastasis: genetic features of lethal metastatic pancreatic cancer obtained from rapid autopsy
Q40484608Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis
Q40063344Loss of heterozygosity predicts poor survival after resection of pancreatic adenocarcinoma
Q39153695Loss of runt-related transcription factor 3 induces gemcitabine resistance in pancreatic cancer
Q88801478Molecular Pathogenesis of Pancreatic Cancer
Q37614592Molecular changes in pancreatic cancer
Q34405057Novel strategies for managing pancreatic cancer.
Q35067751Oncogenic K-Ras and loss of Smad4 mediate invasion by activating an EGFR/NF-κB Axis that induces expression of MMP9 and uPA in human pancreas progenitor cells
Q31147661RPL38, FOSL1, and UPP1 are predominantly expressed in the pancreatic ductal epithelium
Q35587477RUNX3 expression in primary and metastatic pancreatic cancer
Q36685675Target discovery and validation in pancreatic cancer
Q42250458hsa-miR-96 and hsa-miR-217 Expression Down-Regulates with Increasing Dysplasia in Pancreatic Intraepithelial Neoplasias and Intraductal Papillary Mucinous Neoplasms
Q34485753miR-301a as an NF-κB activator in pancreatic cancer cells

Search more.